A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus by Willger, Sven D. et al.
A Sterol-Regulatory Element Binding Protein Is Required
for Cell Polarity, Hypoxia Adaptation, Azole Drug
Resistance, and Virulence in Aspergillus fumigatus
Sven D. Willger
1, Srisombat Puttikamonkul
1, Kwang-Hyung Kim
2, James B. Burritt
3, Nora Grahl
1, Laurel J.
Metzler
4, Robert Barbuch
4, Martin Bard
4, Christopher B. Lawrence
2, Robert A. Cramer Jr.
1*
1Department of Veterinary Molecular Biology, Montana State University, Bozeman, Montana, United States of America, 2Virginia Bioinformatics Institute, Virginia
Polytechnic Institute and State University, Blacksburg, Virginia, United States of America, 3Department of Microbiology, Montana State University, Bozeman, Montana,
United States of America, 4Department of Biology, Indiana University-Purdue University, Indianapolis, Indiana, United States of America
Abstract
At the site of microbial infections, the significant influx of immune effector cells and the necrosis of tissue by the invading
pathogen generate hypoxic microenvironments in which both the pathogen and host cells must survive. Currently, whether
hypoxia adaptation is an important virulence attribute of opportunistic pathogenic molds is unknown. Here we report the
characterization of a sterol-regulatory element binding protein, SrbA, in the opportunistic pathogenic mold, Aspergillus
fumigatus. Loss of SrbA results in a mutant strain of the fungus that is incapable of growth in a hypoxic environment and
consequently incapable of causing disease in two distinct murine models of invasive pulmonary aspergillosis (IPA).
Transcriptional profiling revealed 87 genes that are affected by loss of SrbA function. Annotation of these genes implicated
SrbA in maintaining sterol biosynthesis and hyphal morphology. Further examination of the SrbA null mutant consequently
revealed that SrbA plays a critical role in ergosterol biosynthesis, resistance to the azole class of antifungal drugs, and in
maintenance of cell polarity in A. fumigatus. Significantly, the SrbA null mutant was highly susceptible to fluconazole and
voriconazole. Thus, these findings present a new function of SREBP proteins in filamentous fungi, and demonstrate for the
first time that hypoxia adaptation is likely an important virulence attribute of pathogenic molds.
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Introduction
Aspergillus fumigatus is a normally benign saprophytic fungus that
may cause an often lethal invasive disease in immunocompromised
patients, invasive pulmonary aspergillosis (IPA) [1,2]. Interestingly,
while IPA can be caused by several Aspergillus species, the majority
of IPA cases are caused by A. fumigatus. This may suggest that A.
fumigatus contains unique attributes that allow it to cause disease
[3]. Yet, the mechanisms utilized by A. fumigatus to survive and
cause disease in immunocompromised hosts are not fully
understood [4]. During infection, A. fumigatus causes significant
damage to host tissue through invasive growth by hyphae and
subsequent recruitment of immune effector cells. Thus, infection
generates significant inflammation and necrosis in lung tissue that
can be visualized by histopathology. These pathologic lesions also
likely represent areas of poor oxygen availability to the pathogen
and host.
At sites of Aspergillus infection, direct measurements of oxygen
tension have not been recorded, however, it is well established that
sites of inflammation contain significantly low levels of oxygen
(hypoxia) [5–7]. Moreover, low oxygen tension has been observed
in many compartments of inflamed as well as normal tissues [5–7].
In inflamed tissues, the blood supply is often interrupted because
the vessels are congested with phagocytes [8,9]. Indeed, immune
effector cells such as neutrophils often function effectively in
severely hypoxic microenvironments and have evolved distinct
mechanisms to deal with the absence of oxygen that are dependent
upon the transcription factor hypoxia inducible factor (HIF) 1.
HIF1 is a heterodimeric transcription factor that consists of a
constitutively expressed HIF1b subunit and an oxygen-tension-
regulated HIF1a subunit. [10]. Increased HIF1a protein stability
and activity of the HIF1 complex, in turn, regulate the
transcription of many hypoxia-responsive genes, including those
encoding many glycolytic enzymes, erythropoietin, adrenomedul-
lin, and growth factors [11,12]. Genetic evidence of the
importance of hypoxic environments in the regulation of immune
responses was recently provided by a study of neutrophil-mediated
lung inflammation [13]. Thus, since immune cells of the host have
evolved mechanisms to function in hypoxia, it follows that invasive
fungal pathogens like A. fumigatus are likely subjected to hypoxia
during fungal pathogenesis.
While hypoxic adaptation has not been studied in the context of
A. fumigatus pathogenesis, circumstantial evidence suggests that
hypoxia plays a key role in the pathophysiology of IPA. For
example, it has been postulated that the low rate of Aspergillus
recovery from clinical specimens is due to adaptation by the
fungus to hypoxic microenvironments found at sites of infection
PLoS Pathogens | www.plospathogens.org 1 November 2008 | Volume 4 | Issue 11 | e1000200[14,15]. Furthermore, there are often significant differences in the
in vivo and in vitro test results of antifungal drug efficacies. These
differences have been postulated to be linked to the occurrence of
hypoxia in vivo as demonstrated by recent in vitro antifungal drug
efficacy tests conducted in hypoxia [16,17]. Consequently, it seems
probable that pathogenic molds such as A. fumigatus must possess
mechanisms to adapt to hypoxic microenvironments found in vivo
during infection.
In fact, switching from aerobic respiration to various forms of
anaerobic respiration to deal with low oxygen levels has been
implicated as an important virulence attribute in several
prokaryotic pathogens [18,19]. However, in eukaryotic pathogens,
mechanisms of how these organisms respond and adapt to hypoxia
are largely unknown. Most of our knowledge on how fungi
respond to hypoxia comes from studies in the model yeast
Saccharomyces cerevisiae. Under aerobic conditions, heme biosynthesis
activates the transcriptional regulator Hap1p [20]. Hap1p induces
genes involved in respiration and oxidative stress-responses, but
also activates the transcriptional repressors Rox1p and Mot3p,
that down-regulate genes required for hypoxia adaptation [21].
However, in hypoxic conditions, Rox1p and Mot3p are expressed
and this leads to transcriptional induction of genes involved in
hypoxia adaptation [22]. Thus, hypoxic gene expression in yeast
requires transcription factors that utilize Rox1p-binding sequenc-
es, low oxygen-response elements (LORE), and other regulatory
elements within promoters [23,24]. Since S. cerevisiae is a facultative
anaerobe, it is not surprising that homologs of these key hypoxia
gene regulators have not been found in obligate aerobic
filamentous fungi such as A. fumigatus.
Recently, a novel mechanism of hypoxia adaptation mediated
by a highly conserved family of transcription factors, sterol
regulatory element-binding proteins (SREBPs), was characterized
in fission yeast, Schizosaccharomyces pombe [25]. SREBPs are a unique
family of membrane bound transcription factors first identified in
mammals as regulators of cholesterol and lipid metabolism [26–
30]. Hughes et al. [25] proposed a model in S. pombe where
SREBP (Sre1) and a sterol cleavage activating protein (SCAP,
Scp1) monitor-oxygen dependent sterol synthesis as an indirect
measure of oxygen supply. Importantly, Sre1 was found to be
required for adaptation to hypoxia and regulated approximately
68% of the genes transcriptionally induced greater than 2-fold in
response to anaerobic conditions [31].
Orthologs of Sre1 and Scp1 were recently identified and
characterized in the human fungal pathogenic yeast, Cryptococcus
neoformans [32,33]. As in fission yeast, the SREBP pathway
mediated by Sre1 and Scp1 in C. neoformans was crucial for
adaptation to hypoxia and sterol biosynthesis. Importantly, these
mutants also failed to proliferate in host tissue, failed to cause fatal
meningoencephalitis, and displayed hypersensitivity to the azole
class of antifungal drugs [32,33]. In the yeast S. cerevisiae and
Candida albicans, orthologs of SREBPs do not appear to exist.
However, two similar genes, Upc2 and Ecm22, appear to serve
similar functions as SREBPs. Conserved functions of these genes
include their involvement in the ability of yeast to grow in hypoxia
as well as regulation of sterol biosynthesis and resistance to
antifungal drugs [34–40]. Taken together, these observations
demonstrate an important link between sterol biosynthesis,
hypoxia adaptation, azole drug resistance, and the virulence of
pathogenic yeasts.
In this study, we report the identification and first character-
ization of a Sre1 homolog, SrbA, in an opportunistic pathogenic
mold, A. fumigatus. Our results suggest that while certain aspects of
SREBP function are conserved in yeast and filamentous fungi,
significant differences exist that are unique to molds. Thus, our
results further expand the spectrum of important functions
mediated by SREBPs in eukaryotes, emphasize the importance
of this pathway in human fungal pathogenesis, and suggest
possible clinical significance of SREBPs related to antifungal drug
efficacy.
Results
Identification of srbA in Aspergillus fumigatus
In order to determine if hypoxia adaptation is an important
virulence attribute of filamentous fungi, we first conducted
transcriptional profiling experiments using a long-oligo A. fumigatus
microarray (version 3.0) of wild type A. fumigatus grown under
hypoxic (1% O2) conditions compared to fungus grown under
normal conditions (,21% O2). Analysis of this data revealed ten
putative transcription factors that were transcriptionally induced
more than 2-fold in response to hypoxia and thus could possibly
act as a regulators of genes required for hypoxic adaptation in A.
fumigatus (Willger and Cramer, unpublished data). Further
bioinformatic analyses of these genes revealed that only one,
AFUA_2g01260 (induced 5.02 fold in response to hypoxia), had
similarity with a functionally characterized protein, Sre1 from S.
pombe [25]. Sre1 shares similarity with mammalian SREBP
proteins that regulate lipid and cholesterol homeostasis (reviewed
in [29,30]). In addition, a Sre1 homolog has also recently been
described in the human pathogenic yeast, C. neoformans as a
regulator of hypoxia adaptation and fungal virulence [32,33].
AFUA_2g01260 contains 988 amino acid residues, which
displayed low sequence percent identity with Sre1 from S. pombe
(,13%) and C. neoformans (,10%). However, like Sre1 in both
yeasts, the amino terminus (amino acids 1–425) of
AFUA_2g01260 contains a basic helix-loop-helix (bHLH) leucine
zipper DNA binding domain. In addition, AFUA_2g01260 is
predicted to contain at least one, and likely two, transmembrane
domains. The carboxyl terminus of AFUA_2g01260 is also
predicted to contain a conserved domain of unknown function
(DUF2014) that is found in other SREBP homologs. Consequent-
ly, these results suggest that AFUA_2g01260 is likely the SREBP
homolog in A. fumigatus, and we consequently named this gene srbA
Author Summary
The incidence of potentially lethal infections caused by
normally benign molds has increased tremendously over
the last two decades. One disease in particular, invasive
pulmonary aspergillosis (IPA), caused by the common
mold Aspergillus fumigatus, has become the leading cause
of death due to invasive mycoses. Currently, we have a
limited understanding of how this opportunistic pathogen
causes disease in immunocompromised patients. In this
study, we discover a previously unexplored mechanism
required by this mold to cause disease, hypoxia (low
oxygen) adaptation. We report that hypoxia adaptation in
A. fumigatus is mediated in part by a highly conserved
transcription factor, SrbA, a protein in the sterol regulatory
element binding protein family. A null mutant of SrbA was
unable to grow in hypoxia, displayed increased suscepti-
bility to the azole class of antifungal drugs, and was
avirulent in two distinct murine models of IPA. Importantly,
we report the discovery of a novel function of SrbA in
molds related to maintenance of cell polarity. The finding
that SrbA regulates resistance to the azole class of
antifungal drugs presents an opportunity to uncover
new mechanisms of antifungal drug resistance in A.
fumigatus.
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Additional BLAST analyses revealed that SrbA is highly conserved
amongst the filamentous fungi with putative orthologs found in
plant pathogens such as Magnaporthe grisea and Alternaria brassicicola
and saprophytic molds such as Neurospora crassa and Aspergillus
nidulans.
SrbA is required for hypoxia adaptation in Aspergillus
fumigatus
To determine whether SrbA is involved in hypoxia adaptation
and fungal virulence in filamentous fungi, we generated a null
mutant of the gene encoding SrbA by replacement of the srbA
coding sequence in A. fumigatus strain CEA17 with the auxotrophic
marker pyrG from A. parasiticus as previously described [41,42]
(Figure 1). The resulting DsrbA strain was named SDW1. Ectopic
re-introduction of the wild type srbA allele into SDW1 (resulting in
strain SDW2) allowed us to attribute all resulting phenotypes
specifically to the absence of srbA in SDW1. All strains were
rigorously confirmed with Southern blot (Figure 1) and PCR
analyses (data not shown). The re-introduced srbA allele in SDW2
displayed similar mRNA abundance in response to hypoxia as the
srbA allele in the wild type strain (data not shown). SDW1 and
SDW2 both displayed normal hyphal growth rates compared to
the wild type strain CEA10 in normoxic conditions on glucose
minimal medium (GMM) (Figure 2A) (P.0.01). However, no
hyphal growth of SDW1 was observed in hypoxic (1% O2,5 %
CO2, 94% N2) conditions whereas wild type strain CEA10 and
reconstituted strain SDW2 grew at a normal rate with visual
phenotypic differences in colony color and conidiation compared
to growth in normoxia (Figure 2A and 2B). In hypoxia, the wild
type strains displayed increased aerial hyphae, decreased conidia
production, and consequently exhibited a fluffy colony morphol-
ogy (Figure 2B). After 96 hours of incubation in hypoxia, SDW1
continued to display undetectable growth. However, upon transfer
back to normoxic conditions, wild type growth rate was restored
(data not shown). Addition of exogenous ergosterol or lanosterol
did not rescue the SDW1 growth defect or alter wild type growth
morphology in hypoxia (data not shown). These results indicate
that A. fumigatus can rapidly adapt to hypoxic microenvironments,
and that SrbA in A. fumigatus is involved in mediating this response
by an undefined mechanism.
Transcriptional profiling of SDW1 in response to hypoxia
Given the dramatic phenotype observed in strain SDW1 in
hypoxia and the sequence annotation that SrbA likely functions as
a transcription factor, we next sought to determine which genes
are regulated by SrbA under hypoxic conditions. Microarray
experiments comparing the transcriptional profiles of wild type
strain CEA10 and SDW1 exposed to hypoxia for 24 hours
revealed 87 significant genes possibly regulated by SrbA (Table 1).
Several genes previously shown to be involved in ergosterol
biosynthesis in fungi were found to be transcriptionally repressed
in the absence of SrbA including ERG25, ERG24, and ERG3
(Table 1). Interestingly, besides srbA itself, the gene with the highest
fold difference in expression in SDW1 is a non-ribosomal peptide
synthetase, AFUA_1g10380 (NRPS1 or pes1) [43,44]. In addition,
a significant number of genes involved in cell wall biosynthesis or
homeostasis were observed to be repressed in SDW1 compared to
wild type. These included genes known to be involved in cell wall
biosynthesis such as alpha-galactosidase, alpha-glucosidase B, and
genes involved in cell wall homeostasis such as chitinase. However,
no obvious defects in cell wall biosynthesis were observed in the
Figure 1. Generation and confirmation of a SrbA null mutant in Aspergillus fumigatus. (A) Schematic of wild type (CEA10) and SDW1 (SrbA
null mutant) genomic loci. (B) Southern blot analysis of wild type, SDW1, and SDW2 strains. Genomic DNA from the respective strains was isolated
and digested overnight with NcoI. An approximate 1 kb genomic region of the SrbA locus was utilized as a probe. The expected hybridization
patterns and sizes were observed for the wild type CEA10 (5721 bp) and SrbA mutant (SDW1) (3622 bp) strains. In addition, confirmation of ectopic
reconstitution of the SrbA null mutant was confirmed by the presence of the wild type srbA locus hybridization signal and persistence of the SrbA null
mutant locus (strain SDW2).
doi:10.1371/journal.ppat.1000200.g001
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6 conidia of CEA10, SDW1=DsrbA, SDW2=DsrbA+srbA were
plated on GMM plates and incubated at 37uC under normoxic and hypoxic conditions. (A) The diameter of the colony was measured over 96 h every
24 h. Under normoxic conditions no significant difference in growth speed and colony size or morphology could be observed (P.0.01). (B) Under
hypoxic conditions the wild type CEA10 and the reconstituted strain SDW2 showed comparable growth (P.0.01) but the mutant strain SDW1 did not
demonstrate any detectable growth. Error bars represent standard error from the triplicate experiments.
doi:10.1371/journal.ppat.1000200.g002
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likely indirect effects of the altered cell polarity of the mutant
(discussed below). Genes encoding several transporters were also
found to be regulated by SrbA. Overall, these results suggest some
similarities, such as with regard to ergosterol biosynthesis, with
Table 1. Genes with higher expression in wild type than in
the srbA null mutant in hypoxia.
TRANSPORTERS
AFUA_4g01560 MFS myo-inositol transporter, putative 15.77
AFUA_1g10390 ABC multidrug transporter, putative 15.64
AFUA_3g01670 MFS hexose transporter, putative 14.12
AFUA_2g09450 carboxylic acid transport protein 12.18
AFUA_3g14170 high-affinity hexose transporter 11.31
AFUA_5g06720 MFS sugar transporter, putative 11.04
AFUA_7g06120 transmembrane transporter, putative 10.80
AFUA_3g12720 sugar transporter-like protein 9.08
AFUA_1g13350 transporter, putative 7.65
TRANSCRIPTION REGULATION
AFUA_2g01260 HLH transcription factor, putative (srbA) 38.59
AFUA_3g12910 MmcR, putative 10.49
AFUA_8g00200 CalO6, putative 8.05
AFUA_2g07900 APSES transcription factor (StuA), putative 7.79
AFUA_1g16590 C2H2 transcription factor (BrlA), putative 7.14
AFUA_8g05460 bZIP transcription factor, putative 6.09
STEROL BIOSYNTHESIS
AFUA_8g02440 c-4 methyl sterol oxidase (ERG25) 15.79
AFUA_2g00320 sterol delta 5,6-desaturase (ERG3) 13.57
AFUA_1g03150 c-14 sterol reductase (ERG24) 11.98
OXIDATIVE STRESS RESPONSE
AFUA_1g10380 nonribosomal peptide synthase (NRPS), putative 23.36
AFUA_7g05070 FAD dependent oxidoreductase, putative 13.68
AFUA_5g08830 HEX1 10.66
AFUA_4g08710 short chain dehydrogenase, putative 9.82
AFUA_3g02270 mycelial catalase Cat1 9.15
AFUA_4g14530 theta class glutathione S-transferase 8.45
AFUA_3g01580 GMC oxidoreductase 6.56
AFUA_1g03250 oxidoreductase, short chain dehydrogenase/
reductase family, putative
6.25
CELL WALL RELATED
AFUA_3g08110 cell wall protein, putative 21.29
AFUA_5g14740 fucose-specific lectin 15.00
AFUA_6g00430 IgE-binding protein 12.65
AFUA_5g00840 integral membrane protein 12.21
AFUA_5g03760 class III chitinase ChiA1 7.68
AFUA_4g09600 GPI anchored protein, putative 6.32
AFUA_2g05340 1,3-beta-glucanosyltransferase, putative 6.29
AFUA_1g05790 GPI anchored protein, putative 6.20
AFUA_5g07190 beta-glucosidase 6.04
SECONDARY METABOLISM
AFUA_8g01220 arthrofactin synthetase B 8.38
AFUA_2g17600 polyketide synthetase PksP 6.40
OTHER METABOLIC PROCESSES
AFUA_3g00810 cholestenol delta-isomerase, putative 18.48
AFUA_7g04930 alkaline serine protease (PR1), putative 13.09
AFUA_5g02130 alpha-galactosidase 12.92
AFUA_8g00190 cytochrome P450, putative 11.40
AFUA_1g16250 alpha-glucosidase B 9.95
AFUA_3g12960 cytochrome P450, putative 8.97
AFUA_3g07030 glutaminase A 8.24
AFUA_8g00620 dimethylallyl tryptophan synthase, putative 7.65
AFUA_4g09980 cytochrome P450 monooxygenase, putative 7.15
OTHER AND UNKNOWN GENES
AFUA_6g03680 hypothetical protein 13.55
AFUA_3g07870 conserved hypothetical protein 13.23
AFUA_8g04380 conserved hypothetical protein 12.96
AFUA_8g00710 antimicrobial peptide, putative 12.92
AFUA_3g13110 hypothetical protein 12.88
AFUA_7g01930 ESDC 12.14
AFUA_4g08400 hypothetical protein 11.16
AFUA_6g01870 hypothetical protein 10.71
AFUA_4g14060 conserved hypothetical protein 10.60
AFUA_6g12180 conserved hypothetical protein 10.20
AFUA_6g13980 prenyltransferase, putative 10.04
AFUA_2g00500 conserved hypothetical protein 9.61
AFUA_8g04310 conserved hypothetical protein 9.26
AFUA_1g02290 conserved hypothetical protein 9.13
AFUA_7g05450 SUN domain protein (Uth1), putative 9.02
AFUA_2g15200 conserved hypothetical protein 8.86
AFUA_7g04870 hypothetical protein 8.71
AFUA_5g00700 hypothetical protein 8.69
AFUA_3g07730 hypothetical protein 8.65
AFUA_4g12700 hypothetical protein 8.60
AFUA_5g14920 hypothetical protein 8.59
AFUA_3g07340 hypothetical protein 8.53
AFUA_7g04120 DUF636 domain protein 8.23
AFUA_1g14340 metalloreductase, putative 8.01
AFUA_3g08210 hypothetical protein 7.95
AFUA_5g14680 hypothetical protein 7.80
AFUA_6g11890 dynamin GTPase, putative 7.72
AFUA_2g09030 secreted dipeptidyl peptidase 7.70
AFUA_4g13630 hypothetical protein 7.51
AFUA_2g09680 PB1 domain protein, putative 7.09
AFUA_7g04740 hypothetical protein 6.84
AFUA_3g12230 hypothetical protein 6.81
AFUA_5g02330 major allergen Asp F1 6.81
AFUA_6g14340 related to berberine bridge enzyme (imported) 6.64
AFUA_2g17550 yellowish-green 1 6.56
AFUA_8g04620 hypothetical protein 6.37
AFUA_4g14040 Hsp70 family protein 6.30
AFUA_5g14410 cysteine dioxygenase 6.30
AFUA_2g08820 hypothetical protein 6.24
AFUA_1g13610 SH3 domain protein 5.97
AFUA_4g14050 hypothetical protein 5.73
doi:10.1371/journal.ppat.1000200.t001
Table 1. Cont.
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the overall set of genes putatively regulated by SrbA in A. fumigatus
is significantly different from data obtained from Sre1 mutants in
the yeast S. pombe and C. neoformans. Consequently, these results
strongly suggest that SrbA plays a distinct role in filamentous
fungal biology. These results subsequently directed experiments to
further characterize the role of SrbA in A. fumigatus biology.
SrbA mediates resistance to the azole class of antifungal
drugs
Given the number of ergosterol biosynthesis genes apparently
regulated by SrbA, we next asked the question whether SrbA
mediated resistance to the azole class of antifungal drugs that
target ergosterol biosynthesis. In a screen for susceptibility to
antifungal drugs using E-Test strips (AB Biodisk, kindly provided
by Dr. Theodore White, Seattle Biomedical Research Institute) we
found that SrbA is required for resistance to Fluconazole and
Voriconazole, but not Amphotericin B or Caspofungin. All 3
strains showed equivalent minimal inhibitory concentrations
(MIC) to Amphotericin B (0.25 mg/ml) and Caspofungin
(0.125 mg/ml). The lack of effect of Caspofungin provides support
for our hypothesis that the mutant is likely not directly affected in
cell wall biosynthesis as possibly suggested by the transcriptional
profiling data. However, while CEA10 and SDW2 showed
resistance to Fluconazole as expected, SDW1 growth was inhibited
at the surprisingly low MIC of 1 mg/ml (Figure 3). On the plates
with Voriconazole we could observe that CEA10 and SDW2 were
susceptible as expected (MIC of 0.125 mg/ml respectively). Similar
to the results with Fluconazole, SDW1 was significantly more
susceptible to Voriconazole and showed a MIC of only 0.012 mg/
ml (Figure 3). These clinically significant results suggest that SrbA
mediates resistance to the azole class of antifungal drugs by an
undefined mechanism.
SrbA is required for cell polarity and hyphal
morphogenesis
Visual inspection of SDW1 colony morphology in standard
laboratory conditions did not reveal any apparent morphological
phenotypes (Figure 2B). However, our transcriptional profiling
experiments suggested possible alterations in cell wall biosynthesis,
a critical component of hyphal morphology and growth, in the
absence of SrbA. Consequently, we performed a more in depth
analysis of SDW1 morphology. First, we utilized light microscopy
to examine the growing edges of SDW1 colonies in normoxia. We
observed a significant defect in hyphal tip branching in SDW1 that
is not apparent in strains CEA10 and SDW2 (Figure 4). SDW1
hyphal tips display hyper-branching and a ‘‘blunted’’ abnormal
morphological phenotype (Figure 4). This phenotype suggests that
SrbA is involved in maintaining cell polarity that directs hyphal
growth. Interestingly, this phenotype does not appear to alter the
growth rate of the colony, which was comparable to the wild type
under normoxic conditions (Figure 2A). Next, we utilized
transmission electron microscopy (TEM) to further examine the
cell wall and morphology of conidia and hyphae of SDW1.
Confirming our suspicions that the mutant was not directly
affected in cell wall biosynthesis we observed no clear cell wall
Figure 3. SrbA mediates resistance to Fluconazole (FL) and Voriconazole (VO) in Aspergillus fumigatus. A clear ellipse indicates the
susceptibility to the respective drug. As expected, Fluconazole has no effect on CEA10 and SDW2, but in the absence of SrbA, SDW1 is highly
susceptible to Fluconazole (MIC=1.0 mg/ml). CEA10 and SDW2 are susceptible to Voriconazole (MIC for both=0.125 mg/ml); however, SDW1 also
displays increased susceptibility (MIC=0.012 mg/ml) to this important antifungal agent. The numbers on the scale correspond to the Fluconazole and
Voriconazole concentrations on the E-test strip (in micrograms per milliliter).
doi:10.1371/journal.ppat.1000200.g003
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between the cell wall and plasma membrane is observed in SDW1
conidia and hyphae compared with the wild type (Figure 5A and
5B and 5D and 5E). A striking phenotype was consequently
observed in conidia from SDW1 that suggested a significant defect
in the cell wall-plasma membrane interface occurs in the absence
of SrbA (Figure 5A and 5B). This defect is apparently exacerbated
by the electron beam, which causes a separation between the cell
wall and plasma membrane in SDW1 conidia (Figure 5C). This
phenotype was observed in over 80% of the SDW1 conidia
examined. However, the size and density of the mutant conidia
were comparable to the wild type strain as measured by flow
cytometry (data not shown). Since a defect in the cell wall plasma
membrane interface was suggested, we examined viability of the
SDW1 conidia by monitoring germination. These experiments
revealed that viability, as measured by conidia germination, was
not significantly different between the wild type, SDW1 and
SDW2 strains (Figure 6) (P.0.01). Similar cell wall-plasma
membrane defects were observed in the SDW1 hyphae compared
with the wild type hyphae (Figure 5D and 5E). Importantly, an
accumulation of electron dense objects was observed in the SDW1
hyphae. We hypothesize that these objects may be vesicles of the
Spitzenko ¨rper, and their abnormal location in the SDW1 hyphae
may cause the observed altered cell polarity (Figure 5E and 5H).
This phenotype was observed in over 50% of the SDW1 hyphae
examined and never observed in the wild type strain. These results
suggest that SrbA is critical for maintaining the cell wall – plasma
membrane interface, and that SrbA is critical for normal hyphal
branching and cell polarity in filamentous fungi by an undefined
mechanism.
SrbA is required for normal sterol biosynthesis
Transcriptional profiling of SDW1 under hypoxia suggested
that SrbA was involved in both early and late steps of the sterol
Figure 4. Hyphal morphology and growth of wild type strain
CEA10 and SrbA null mutant SDW1. Strains were grown overnight
on slides coated with GMM. Brightfield microscopy pictures of wild type
CEA10 and SDW1 at 200-fold and 400-fold magnification. SDW1 showed
abnormal hyphal formation and apparent cell polarity defect with
multiple branches and unusual thick structures at the apical tips of the
hyphae. Bars=100 mm.
doi:10.1371/journal.ppat.1000200.g004
Figure 5. Abnormal cell wall-plasma membrane interface and
hyphal morphology is evident in the absence of SrbA. (A–C)
Transmission electron micrographs showing sections of conidia of wild
type CEA10 (A) and SDW1 (B,C). Compared with the round wild type
conidia having clear boundaries between plasma membrane and cell
wall layers, most of the SDW1 conidia were distorted in shape and
possessed faint, somewhat shriveled boundaries. Note that frequent
‘‘tearing’’ took place mainly at the cell wall – plasma membrane
interface during microscopic examination of the SDW1 conidia (arrows).
This phenotype was observed in over 80% of SDW1 conidia examined.
Inset panels depict a 36magnified view of the conidial cell wall region.
Bars=500 nm. (D–H). Transmission electron micrographs showing
longitudinal and transverse hyphal sections of wild type CEA10 (D,F)
and SDW1 (E,G,H). Close observation of the hyphal tips show
phenotypic differences between wild type and SDW1. Abnormal cell
wall – plasma membrane interfaces and apical swellings in SDW1
hyphae were frequently observed, while the wild type showed normal
round-shaped apexes. With respect to cell wall morphology around the
hyphal apex, SDW1 had an abnormally expanded cell wall (arrows)
containing numerous electron dense objects (arrowheads), which likely
resulted in hyphal tip bending (H). Inset panels depict a magnified view
of the boxed region. Bars=1 mm, except for the inset panels of E and H
where they denote 500 nm.
doi:10.1371/journal.ppat.1000200.g005
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hyphal morphology observed via light microscopy and TEM
micrographs in SDW1 also suggested possible alterations in sterol
content in the absence of SrbA. Thus, we examined the sterol
profile of the SrbA null mutant SDW1 by GC-MS and compared
it with the wild type strain CEA10. The GC-MS profiles
demonstrated a significant accumulation of 4-methyl sterols in
the SrbA null mutant, SDW1, that was not observed in the wild
type strain CEA10 (Figure 7). Interestingly, both strains possessed
significant amounts of ergosterol (Figure 7). The ratio of C-4
methylated sterols to ergosterol in the absence of SrbA is 1.94
whereas no C-4 methylated sterols accumulated in the wild type.
Specifically, the accumulation of 4-methylfecosterol and 4,4-
dimethylergosta-8,24(28)-dien-3b-ol in the absence of SrbA
suggests a blockage at ERG25 in the sterol biosynthesis pathway
in SDW1. These alterations are supported by the transcriptional
profiling data, which suggests transcriptional regulation of ERG25
by SrbA in A. fumigatus (Table 1). Consequently, these results
suggest a blockage of C4 demethylation in the absence of SrbA in
A. fumigatus. In addition, these results suggest that ergosterol can
still be synthesized in the absence of SrbA in A. fumigatus.
SrbA is required for fungal virulence in two distinct
murine models
Next, we sought to determine whether SrbA was required for A.
fumigatus virulence. To answer this important question, we utilized
two distinct murine models of IPA. In the first model, outbred
CD1 neutropenic mice infected with SDW1 displayed no
symptoms associated with IPA (Figure 8A). This was in contrast
to mice infected with the wild type CEA10 and reconstituted strain
SDW2 that displayed well described symptoms of A. fumigatus
infection including hunched posture, ruffled fur, weight loss, and
increased respiration. Consequently, a significant difference in
mortality was observed between the mice infected with SDW1 and
mice infected with either SDW2 or CEA1O (P=0.0002). Indeed,
in this murine model, the SDW1 strain was completely avirulent
(Figure 8A). We next asked the question whether mice infected
with SDW1 were able to clear the infection. After 28 days, SDW1
Figure 6. Conidia germination is not affected by loss of SrbA. Germination media was inoculated with approximately 10
6 conidia/ml of the A.
fumigatus strains CEA10, SDW1, and SDW2. After 7 hours the germination rate was determined by counting a total of 100 spores and noting the
number of germinated spores. Three replicates were performed. No significant difference in germination was observed between CEA10, SDW1, and
SDW2 (P.0.01).
doi:10.1371/journal.ppat.1000200.g006
Figure 7. C4-demethylation is altered in the absence of SrbA.
Representative GC-MS chromatograms of sterol extracts from wild type
(A) and SDW1 (B). Key: A- ergosta-5,8,22-trien-3b-ol, B- ergosterol, C-
ergosta-5,7,22,24(28)-tetraen-3b-ol, D- ergosta-5,7,24(28)-trien-3b-ol, E-
24-ethylcholesta-5,7,22-trien-3b-ol, F- 4-methylfecosterol, G- 4methyler-
gosta-5,8,24(28)-trien-3b-ol, H- 4,4-demethylergosta-8,24(28)-dien-3b-ol.
An accumulation of 4-methyl sterols is observed in the absence of SrbA,
suggesting a blockage in enzymes involved in sterol C-4 demethylation.
The ratio of C-4 methylated sterols to ergosterol in the absence of SrbA
was 1.94 whereas no C-4 methylated sterols accumulated in the wild
type.
doi:10.1371/journal.ppat.1000200.g007
Characterization of a SREBP in A. fumigatus
PLoS Pathogens | www.plospathogens.org 8 November 2008 | Volume 4 | Issue 11 | e1000200infected mice displayed no visible or microscopic signs of infection.
In particular, at days 14, 21, and 28 lung homogenates were taken
from SDW1 infected mice and with the exception of one mouse,
no fungal colonies were recoverable indicating that the mice had
cleared the infection. Histopathological analyses of mice on days
14, 21 and 28 in this neutropenic model also confirmed the lack of
fungal persistence and inflammation in mice infected with SDW1
(Figure 9).
Next, we examined the virulence of SDW1 in a murine model
of X-linked chronic granulomatous disease (X-CGD) utilizing
gp91
phox2/2 mice. These mice are deficient in NADPH oxidase
activity and display hyper-susceptibility to Aspergillus species
without the need for immunosuppression with chemotherapeautic
agents [45,46]. Similar to the neutropenic mouse model, X-CGD
mice infected with strain SDW1 had significant differences in
survival compared with mice infected with wild type and
Figure 8. Role of SrbA in Aspergillus fumigatus virulence. (A) Outbred CD-1 mice (n=12) were immunosuppressed by i.p. injection of
cyclophosphamide (150 mg/kg) 2 days prior to infection and s.c. injection of Kenalog (40 mg/kg) 1 day prior to infection and injection of 150 mg/kg
cyclophosphamide 3 days post-inoculation and 40 mg/kg Kenalog 6 days post-inoculation. Mice were inoculated intranasally with 10
6 conidia in a
volume of 40 ml of wild type CEA10, DsrbA mutant strain SDW1 and the srbA reconstituted strain SDW2. P value for comparison between SDW1 and
wild type CEA10, P=0.0002. (B) gp91
phox2/2 mice (n=6) were challenged intratracheally with 10
6 conidia in a volume of 40 ml of wild type CEA10,
DsrbA mutant strain SDW1 and the srbA reconstituted strain SDW2. A log rank test was used for pair wise comparisons of survival levels among the
strain groups. P value for comparison between SDW1 and wild type CEA10, P=0.0054. SDW1 is significantly less virulent than the wild type CEA10
and the reconstituted strain SDW2 in both murine models. All animal experiments were repeated in duplicate with similar results.
doi:10.1371/journal.ppat.1000200.g008
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nic mouse model, these mice all displayed symptoms of IPA during
the preliminary stages of infection. These symptoms, likely due to
the large inflammatory response characteristic of these mice when
exposed to fungal antigens, included ruffled fur, hunched posture,
and lethargic movement as early as 24 hours post-infection.
However, only one mouse infected with SDW1 succumbed to the
infection. In a repeat experiment, 3 additional X-CGD mice
infected with SDW1 also succumbed on day 4 to the infection.
Most likely, this was due to the hyper-inflammatory response that
occurs in X-CGD mice and not death due to invasive fungal
growth. Regardless, the majority of X-CGD mice infected with
SDW1 survived the infection and displayed no symptoms of IPA
by day 14. Histopathological analyses of these mice displayed
standard pathological findings associated with Aspergillus infections
in X-CGD mice including the development of granulomatous like
lesions, massive influx of inflammatory cells (primarily neutrophils)
to sites of infection, subsequent peribronchiolar and alveolar
inflammation, and substantial fungal growth in silver stained tissue
(Figures 10 and 11). On day 1 of the infection, fungal germination
and growth is observed in mice infected respectively with all 3
strains of the fungus. This observation confirms the viability of
SDW1 conidia in vivo (Figure 10). Semi-quantitative assessment of
the percent of the lung affected by the infection, measured by
inflammation and necrosis, of mice infected with the 3 strains
respectively revealed no difference at this early time point
(CEA10=1.360.5, SDW1=1.360.5, SDW2=160.0). Histopa-
thology on day 4 of the infection, however, revealed extensive
growth and proliferation of the wild type and reconstituted SDW2
strain, but minimal fungal growth and proliferation in mice
infected with the SrbA null mutant SDW1 (Figure 11). Semi-
quantitative assessment of the inflammation and necrosis observed
in the lungs of mice infected with the 3 strains respectively at this
time point revealed significant differences in the percent of the
lung affected by the infection (CEA10=3.360.5,
SDW1=2.360.5, SDW2=3.860.5). Lung homogenates from
these mice also revealed that viable SDW1 fungus was recoverable
from these mice at this time point. This data is consistent with the
observed in vitro phenotype of the SDW1 strain in hypoxia.
Histopathological analysis of SDW1 infected survivors in this
model revealed persistence of granuloma like structures and fungal
tissue (Figure 12). Lung homogenates from these animals revealed
that the observed fungal tissue was still viable. These results
indicate that despite normal growth rates in vitro in normoxic
conditions, the SDW1 strain is severely attenuated in its ability to
cause lethal disease in two distinct murine models of IPA.
Figure 9. Representative histopathology of CD-1 mouse model
SDW1 infected survivors. Hematoxylin and eosin (H&E) or Gom-
mori’s methenamine silver (GMS) stains at 100-fold magnification. No
sign of inflammation or fungal burden was observed in any surviving
animal on day +14, +21 and +28 of the infection. This result indicates
that in this murine model, the immune system is capable of clearing the
fungal infection in the absence of SrbA. Bar=100 mm.
doi:10.1371/journal.ppat.1000200.g009
Figure 10. Histopathology of X-CGD mouse model 24 hours
after infection. Mock=0.01% Tween inoculated, WT=CEA10,
SDW1=DsrbA, SDW2=DsrbA+srbA. Mice were inoculated with 1610
6
conidia intratracheally, euthanized on day +1 after inoculation, lungs
removed, fixed in formaldehyde, and stained with hematoxylin and
eosin (H&E) or Gommori’s methenamine silver (GMS) stain. On day 1 no
difference in size and state of lesions could be observed in the infected
mice. GMS staining revealed that fungal colonization and germination is
observed in all infected animals but not the mock control. This result
indicates that SDW1 conidia are viable in vivo during the early stages of
infection. Bar=100 mm.
doi:10.1371/journal.ppat.1000200.g010
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resistance to macrophage killing
One possible mechanismthatcould explainthe virulencedefect of
strain SDW1 is an increased susceptibility to oxidative stress as
suggested by transcriptional profiling and altered conidia morphol-
ogy. We examined the growth of CEA10, SDW1, and SDW2 in the
presence of 1 mM and 2.5 mM hydrogen peroxide on glucose
minimal media. After 48 hours, we observed no detectable
difference in growth morphology or colony diameter. In addition,
we next examined the ability of RAW264.7 macrophage-like cells to
kill SDW1 conidia (Figure 13). As presented in figure 13, no
significant difference in conidia killing was observed between
CEA10, SDW1, and SDW2 (P.0.01). We conclude that increased
susceptibility to oxidative stress and macrophage killing is not
responsible for the virulence defect observed in the absence of SrbA.
Discussion
In this manuscript we present the first characterization of a
SREBP in a filamentous fungus. In the yeasts S. pombe and C.
neoformans, SREBP homologs are crucial for sterol biosynthesis,
survival under hypoxic conditions, resistance to azole antifungal
agents, and fungal virulence [25,32,33]. Our results confirm that
some roles of SREBPs in filamentous fungi are conserved with
yeast including, the response to hypoxia, sterol biosynthesis, and
susceptibility to the azole class of antifungal drugs. However, our
results suggest additional functions of SREBPs in filamentous
fungi, most importantly a role in maintenance of cell polarity.
Similarities and differences between SrbA in A. fumigatus and
Sre1 in the yeast S. pombe and C. neoformans were apparent from
transcriptional profiles comparing the SREBP null mutants to
their respective wild type strains in response to hypoxia. Unlike C.
neoformans, we did not observe SrbA dependent genes involved in
iron or copper uptake in A. fumigatus [32]. This may, however, be a
reflection of the experimental conditions that did not place iron
stress on the fungus in these experiments. Similar to C. neoformans
and S. pombe, we observed SrbA dependent genes involved in
ergosterol biosynthesis including ERG25, ERG24, and ERG3
[31–33]. This result suggests that regulation of ergosterol
Figure 11. Histopathology of X-CGD mouse model day 4 after infection. Mock=0.01% Tween inoculated, WT=CEA10, SDW1=DsrbA,
SDW2=DsrbA+srbA. Mice were inoculated with 1610
6 conidia intratracheally, euthanized on day +4 after inoculation, lungs removed, fixed in
formaldehyde, and stained with hematoxylin and eosin (H&E) or Gommori’s methenamine silver (GMS) stain. Significant inflammation, necrosis, and
an influx of immune effector cells (primarily neutrophils) is observed on day +4 in all infected animals but not the mock control. However, lesions are
more localized and not as extensive in mice infected with SDW1. Open alveoli and more localized inflammation are clearly observed in mice infected
with SDW1. Interestingly, GMS staining revealed that fungal growth is less extensive in SDW1 as well. This result indicates that as the infection
progresses, SDW1 is incapable of continued hyphal growth despite the absence of NADPH oxidase in this murine model. Bar=500 mm for 406;
Bar=100 mm for 2006.
doi:10.1371/journal.ppat.1000200.g011
Characterization of a SREBP in A. fumigatus
PLoS Pathogens | www.plospathogens.org 11 November 2008 | Volume 4 | Issue 11 | e1000200biosynthesis is a conserved function of SREBPs in fungi. In A.
fumigatus, the SrbA dependent regulation of ERG25 seems to be of
particular significance as sterol profiles of the SrbA mutant
indicated an accumulation of C-4 methyl sterols suggesting a block
in ERG25 function. The effects of decreased ERG3 and ERG24
transcription in the SrbA null mutant is less clear. The
accumulation of pathway intermediates may subsequently affect
the expression of these genes, and thus, their regulation by SrbA
may be indirect. Moreover, A. fumigatus is predicted to have 3
possible orthologs of ERG3 and two of ERG24, which likely
indicates a complex regulatory mechanism for ergosterol biosyn-
thesis in A. fumigatus that is mediated in part by SrbA under specific
conditions such as hypoxia [47,48]. Indeed, single mutants of erg3
genes result in no difference in their sterol profiles compared with
wild type strains [49].
Other differences with yeast in the transcriptional profile of the
SREBP mutant in A. fumigatus suggest important roles for SrbA in
filamentous fungal biology. For example, a non-ribosomal peptide
synthetase, NRPS1 (or pes1), had the highest change in expression
between wild type and the SrbA null mutant [43,44]. This NRPS
has been observed to mediate resistance to oxidative stress in A.
fumigatus and displayed an attenuated virulence phenotype in a
Galleria mellonella (wax moth) model of aspergillosis depending on
inoculum dose [44]. NRPSs are not generally found in most yeast
and are particularly abundant in filamentous fungi. Thus, this
result suggests that the uncharacterized peptide produced by this
NRPS may possibly be involved in hypoxia adaptation as
regulated by SrbA in filamentous fungi. Interestingly, we did not
observe any increased susceptibility to oxidative stress in the SrbA
null mutant. Overall, however, unlike C. neoformans and S. pombe,
we did not observe any genes with an annotation that would
clearly point to a role in allowing Aspergillus to adapt to hypoxia.
This result further illustrates that mechanisms of hypoxia
adaptation are almost certainly different in molds than yeast.
Our examination of the SrbA null mutant colony morphology
subsequently revealed abnormal branching at the hyphal tips in
normoxia and an inability of hyphal growth in hypoxia. Further
examination of the mutant with TEM suggested altered vesicle
Figure 12. Representative histopathology of X-CGD mouse
model SDW1 infected survivors. Hematoxylin and eosin (H&E) or
Gommori’s methenamine silver (GMS) stains. Resolution of inflamma-
tion and necrosis is observed in all surviving animals on day +14 of the
infection. However, lesions are still apparent as is common in these
mice, but necrosis and debris is significantly reduced. Fungal tissue
remains evident on GMS stains indicating that despite surviving the
infection, these mice have not entirely cleared the fungal infection. This
result confirms the importance of a functional NADPH oxidase in
resistance to Aspergillus infections, and suggests that increased hypoxia
prevents proliferation of fungal tissue in the absence of SrbA.
Bar=500 mm for 406; Bars=100 mm for 1006and 2006.
doi:10.1371/journal.ppat.1000200.g012
Figure 13. Loss of SrbA does not affect susceptibility to conidia killing by RAW264.7 cells. RAW264.7 cells (macrophages) were infected
with a total of 1.25610
6 freshly harvested A. fumigatus conidia of strains CEA10, SDW1, and SDW2 to obtain a conidia:macrophage ratio of 5:1.
Conidia and macrophages were incubated together for 6 hours. After 6 hours, conidia were collected from the macrophages and plated onto
glucose minimal media. Shown is the percent of recovered conidia after 6 hours incubation of two biological replicates. No significant difference in
conidia killing was observed between CEA10, SDW1, and SDW2 (P.0.01).
doi:10.1371/journal.ppat.1000200.g013
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these electron dense objects, which we hypothesize are vesicles,
comprise the actual Spitzenko ¨rper. At the apex of hyphae in
filamentous fungi, the Spitzenko ¨rper is an accumulation of vesicles
that is critical for growth directionality [50,51]. Interestingly,
Takeshita et al. (2008) recently observed that localization of key
deposition proteins involved in polarized growth at the hyphal tip
requires apical sterol-rich membranes [52]. Thus, we hypothesize
that the altered hyphal morphology and excessive branching at the
tips observed in the SrbA null mutant is due to the alteration in
sterol composition of the sterol-rich microdomains in the
membrane that are critical for localization of important vesicles
and landmark proteins [53]. The alteration in sterol content may
cause improper sorting of the vesicles to the apex of the hyphal tip.
It is also likely then that the inability of the mutant to grow in
hypoxia is related to the perturbation in sterol biosynthesis, a
highly oxygen dependent pathway reported to require at least 22
molecules of oxygen.
We could not rescue the SrbA phenotype in hypoxia with
addition of ergosterol or lanosterol (data not shown). Nor did
exogenous addition of these sterols alter growth of the wild type
strain in hypoxia as is the case for S. cerevisiae, which requires
exogenous sterols for anaerobic growth. These results may suggest
that A. fumigatus does not import exogenous sterols in hypoxic
conditions, that SrbA may be in part responsible for exogenous
sterol uptake, or that the defect is not due to loss of ergosterol or
lanosterol. We feel that the latter explanation is most likely as A.
fumigatus has been observed to take up and utilize exogenous
cholesterol [54]. We observed that the A. fumigatus SrbA null
mutant produced substantial levels of ergosterol even in the
absence of SrbA. Thus, even though the ergosterol biosynthesis
pathway appears blocked at ERG25 in the SrbA mutant,
alternative mechanisms exist for A. fumigatus to produce ergosterol
in the absence of SrbA and presumably ERG25 activity. This
finding is consistent with a recent report which suggested that A.
fumigatus likely possess at least three alternative pathways for
ergosterol biosynthesis [48]. Also, an analysis of the A. fumigatus
genome sequence revealed that A. fumigatus contains duplicate and
even triplicate copies of many of the ergosterol biosynthesis genes
[47,55]. Thus, it appears that A. fumigatus contains complex
regulatory mechanisms, of which SrbA is a part, for the
production of ergosterol that remain to be elucidated.
Based on our current knowledge of the pathophysiology of IPA,
the in vitro phenotypes observed in the SrbA mutant would not
predict a role for this protein in A. fumigatus virulence. However,
the SrbA null mutant was virtually avirulent in two distinct murine
models of IPA despite a normal growth rate of the fungus in
standard laboratory conditions. Consequently, we believe two
possible explanations exist for the observed avirulent phenotype of
the SrbA null mutant. First, and we believe most likely, the
inability of the SrbA null mutant to grow in hypoxia prevents
invasive disease from being established. Once hypoxia is generated
during Aspergillus infection, the mutant simply can no longer grow
and proliferate, allowing what immune effector cells that remain
functional the ability to ultimately clear the infection. An
alternative hypothesis is that the altered hyphal morphology and
excessive branching observed in the SrbA mutant in normoxic
conditions results in a strain incapable of invasive growth or a
strain more susceptible to clearance by the immune system. To
examine these alternatives, we employed the use of two distinct
murine models of IPA.
We first examined the SrbA mutant virulence phenotype in a
persistently neutropenic mouse model characterized by the use of
high doses of cyclophosphamide and Kenalog [42]. Currently, it is
unclear what specific components of the immune system are
affected in this model, but it is clear that differences in the
immunosuppression regimen can significantly affect the outcome
of infection [56,57]. In this model, significant inflammation and
tissue necrosis is observed in histopathological examinations. We
hypothesize that these sites of infection and inflammation in this
model are hypoxic. Thus, we believe that A. fumigatus must
overcome significant hypoxia during pulmonary infections, and
the inability of the SrbA null mutant to adapt to hypoxic
conditions results in rapid cessation of invasive growth and a lack
of lethal disease. Our histopathological findings with the SrbA
mutant strain revealed fungal growth in this model early in the
infection. However, by day 14, we were unable to recover viable
colonies from mice infected with the SrbA null mutant strain.
Indeed, by day 14 of the infection, little evidence of inflammation
or fungal burden was evident in mice infected with the SrbA null
mutant. These two results suggest that growth of the fungus was
halted and what immune effector cells present in the immuno-
suppressed mice were able to clear the infection. Furthermore, our
in vitro experiments revealed that the growth defect of the SrbA
mutant in hypoxia was not fungicidal but fungistatic. Thus, if
growth simply were halted in the animals without immune system
clearance, we would have expected to recover viable fungal
colonies from the infected mice.
To further examine the apparent virulence defect of the SrbA
null mutant, we utilized a mouse strain highly susceptible to
Aspergillus infections, the X-CGD gp91
phox2/2 mice [45,46]. These
mice exhibit a hyper-inflammatory response when exposed to A.
fumigatus and other Aspergillus species. We chose this particular
animal model for our experiments given the very specific defect in
NADPH oxidase function in these mice, and with the hypothesis
that the hyper-inflammatory response would generate significant
hypoxia in the lung. Given the extreme susceptibility of these mice
to A. fumigatus, we hypothesized that if the SrbA null mutant could
grow and persist in vivo, even at a reduced rate, we should observe
significant mortality in these mice. However, in contrast, we
observed limited mortality in these mice when inoculated with the
SrbA null mutant, strongly suggesting that the mutant simply
cannot grow effectively in vivo to cause invasive disease. Unlike the
neutropenic mouse model, extensive signs of chronic inflammation
remained evident in the X-CGD mice post-day 14, consistent with
previously reported results in these animals [45]. Furthermore,
unlike the neutropenic mice, we could detect the persistence of
viable SDW1 in the lungs of these surviving mice out to day 14.
Consequently, we conclude that these observations strongly
suggest that the inability of the SrbA null mutant to grow in
hypoxic microenvironments is primarily responsible for the
avirulent phenotype of the mutant. Though the altered cell
polarity of the SrbA mutant may contribute to the virulence
defect, the fact that SrbA null mutant displayed normal growth
rates in vitro in standard laboratory growth conditions suggests to us
that the altered cell polarity did not significantly affect fungal
growth. Furthermore, we also have examined the susceptibility of
the SrbA null mutant conidia to macrophage (RAW264.7 cells)
killing and found no difference with the wild type strain. In
addition, the SrbA mutant did not display increased sensitivity to
hydrogen peroxide. Taken together, we feel these observations
strongly suggest that the virulence defect in the SrbA null mutant is
due to its inability to grow in hypoxia.
An additional observation of clinical significance was the finding
that SrbA mediates resistance to the azole class of antifungal drugs.
Interestingly, loss of SrbA resulted in a strain of A. fumigatus highly
susceptible to fluconazole, an azole that normally has minimal
activity against A. fumigatus [58,59]. The mechanism(s) behind this
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SrbA mutant revealed numerous transporters possibly regulated
by SrbA. Thus, the mechanism behind the increased azole
susceptibility may be due to loss of transcription in specific
transporters in the SrbA mutant. This hypothesis is currently being
tested in our laboratory. Second, a relationship between
mitochondria function, sterol homeostasis, and azole drug
resistance has been observed in the yeast S. cerevisiae and Candida
glabrata [60,61]. Thus, the altered accumulation of sterol
intermediates in the SrbA mutant may alter the resulting
interaction with fluconazole and mitochondria. With a similar
increase in susceptibility to azoles in the SREBP mutant in C.
neoformans, it seems clear that further study of the SREBP pathway
and azole drug resistance in pathogenic fungi is highly warranted.
Identification of ways to inhibit this pathway in vivo may increase
the efficacy of current azole antifungal agents [32,33]. Thus,
further studies are needed to dissect this important pathway in
yeast and molds to identify conserved targets that may be
harnessed to treat patients with invasive mycoses.
Finally, in this study, we did not focus on elucidating the
molecular mechanism behind SrbA regulation and activation in
molds. However, several observations from our studies hint at
possible mechanisms. First, we identified SrbA in a transcriptional
profiling screen of A. fumigatus in response to hypoxia (induced .5
fold). This suggests that SrbA may be transcriptionally regulated in
molds. However, HIF1 in humans also responds transcriptionally
to hypoxia, but its activity is primarily post-translationally
regulated [62,63]. In the yeast S. pombe and C. neoformans, it seems
clear that Sre1 is regulated post-translationally in response to sterol
biosynthesis perturbation that occurs in low oxygen environments.
Indeed, Hughes et al. (2007) have identified 4-methyl sterols as the
primary activating agent of Sre1 in S. pombe [64]. Thus, our finding
that the SrbA null mutant in A. fumigatus accumulates 4-methyl
sterols may also suggest that these sterols are the trigger for SrbA
activation in A. fumigatus.
While many of the phenotypes we observed in the SrbA mutant
in A. fumigatus may suggest that SrbA is regulated in a similar
manner as Sre1 in yeast, our results may also suggest an alternative
model in molds. First, despite extensive bioinformatic analyses, we
were unable to identify a clear homolog of the sterol cleavage
activating protein (SCAP). SCAP is highly conserved in yeast,
mammals, and insects and thus it is surprising that bioinformatic
searches were unable to identify a clear homolog in any
filamentous fungi with genome sequences available. However,
some candidates with minimal sequence similarity are being
pursued in our laboratory. Second, the observation that sterol
biosynthesis was altered in normoxia, likely resulting in altered cell
polarity, suggests that in molds, SrbA plays a significant role in the
biology of filamentous fungi in normoxic conditions. Third,
though sequence identity was extremely low, generation of null
mutants in putative site-1 (S1P) and site-2 (S2P) protease homologs
in A. fumigatus did not demonstrate expected defects in hypoxic
growth (Willger and Cramer, unpublished data). Additional
proteases remain to be explored. We could, however, identify a
clear Insig1 homolog, which we have named InsA. In mammals,
Insig is a key regulator of SREBP function where it binds to SCAP
and prevents SREBP cleavage in the presence of sterols by
maintaining the SREBP-SCAP complex in the endoplasmic
reticulum membrane [65,66]. We are currently characterizing a
possible role for InsA in SREBP signalling in filamentous fungi.
Interestingly, C. neoformans lacks an apparent Insig homolog and
the Insig homolog in S. pombe does not appear to be required for
regulation of SREBP signalling [25,32]. Taken together, these
results suggest that while aspects of SrbA signalling in filamentous
fungi may be conserved in yeast and mammals, it is likely that
significant differences exist in molds that remain to be elucidated.
What is clear, however, is that SREBPs play critical roles in the
biology of fungi that have important implications for fungal
virulence and how we manage and treat invasive fungal infections.
Future studies on this pathway in A. fumigatus are likely to yield
important insights into sterol metabolism, hypoxia adaptation,
fungal growth, and mechanisms of azole drug resistance.
Materials and Methods
Strains and media
A. fumigatus strain CEA17 (a gift from Dr. J.P. Latge ´, Institut
Pasteur) was used to generate the srbA null mutant strain, SDW1
(DsrbA::A. parasiticus pyrG pyrG1). A. fumigatus strain CEA17 is a
uracil-auxotrophic (pyrG1) mutant of A. fumigatus strain CEA10
[67,68]. In this study we used CEA10 (gift from Dr. Thomas
Patterson, University of Texas- San Antonio Health Sciences
Center) as the wild type, SDW1, and an ectopic complemented
control strain SDW2 (Dsrb::A. parasiticus pyrG+srbA). All strains were
stored as frozen stocks with 50% glycerol at 280uC. The strains
were routinely grown in glucose minimal medium (GMM) with
appropriate supplements as previously described [69] at 37uC. To
prepare solid media 1.5% agar was added before autoclaving.
Strain construction
Generation of a srbA null mutant in A. fumigatus strain CEA17
was accomplished by replacing an ,2.2-kb internal fragment of
the srbA coding region (,3.0 kb; GenBank accession
no. XM_744169) with A. parasiticus pyrG. The replacement
construct was generated by cloning a sequence homologous to
the srbA locus into plasmid pJW24 (donated by Dr. Nancy Keller,
University of Wisconsin—Madison). Homologous sequences, each
,1 kb in length and 59 and 39 of the srbA coding sequence, were
cloned to flank A. parasiticus pyrG in pJW24. The resulting plasmid,
pSRBAKO, was used as a template to amplify the ,5.1-kb
disruption construct for use in fungal transformation. To
complement the DsrbA strain SDW1 the srbA gene was amplified
using genomic DNA of CEA10 as template and the primers
59SrbAKOLF and 39SrbAKORF. The ,5.9-kb PCR product was
used in a fungal transformation and selection was for colonies able
to grow under hypoxic conditions. The primers utilized in vector
construction are presented in Table S1.
Generation of fungal protoplasts and polyethylene glycol-
mediated transformation of A. fumigatus were performed as
previously described [70]. Briefly, 10 mg of the srbAKO PCR-
generated replacement construct was incubated on ice for 50 min
with 1610
7 fungal protoplasts in a total volume of 100 ml.
Transformants were initially screened by PCR to identify potential
homologous recombination events at the srbA locus. PCR was
performed with primers designed to amplify only the disrupted
srbA locus (59SrbAKOLF and 39PyrGKOLF; 59PyrGKORF and
39SrbAKORF) (Table S1). Homologous recombination was
confirmed by Southern analysis with the digoxigenin labeling
system (Roche Molecular Biochemicals, Mannheim, Germany) as
previously described [71]. To eliminate the chance of heterokary-
ons, each transformant was streaked with sterile toothpicks a
minimum of two times to obtain colonies from single conidia.
Hypoxic cultivation
Strains were grown on GMM plates at 37uC. Normoxic
conditions were considered general atmospheric levels within the
lab (,21% O2). For hypoxic conditions a Hypoxia Incuba-
tion Chamber (MIC-101; Billups-Rothenberg, http://www.
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37uC and kept at ,1% oxygen level utilizing a gas mixture
containing 1% O2,5 %C O 2 and 94% N2. In addition, hypoxia
experiments requiring shake-flask cultures were conducted in a
Biospherix C-Chamber with O2 levels controlled by a PRO-Ox
controller and CO2 levels controlled with PRO-CO2 controller
(Biospherix, Lacona, NY). For these experiments, O2 set point was
1% and CO2 set point was 5%.
Colony growth was quantified as previously described [72].
Briefly, 5-ml aliquots containing 1610
6 conidia from freshly
harvested GMM plates were placed in the center of GMM agar
plates. Plates were then cultured under normoxic or hypoxic
conditions. Diameters of three colonies per A. fumigatus strain and
condition were measured once daily over a period of 4 days. The
average change in colony diameter per 24 h of growth was
calculated from three independent cultures. Conidia were
harvested with 20 ml of sterile 0.01% Tween 80, filtered through
two layers of sterile miracloth (EMD Biosciences, La Jolla, CA),
and quantified.
Isolation of total RNA
Conidia from freshly harvested GMM plates were inoculated in
5 ml GMM in a 6-well plate to a concentration of 1610
7/ml.
Cultures were grown aerobically for 24 h. For normoxic growth,
cultures were maintained in atmospheric conditions. For hypoxic
growth, cultures were placed in the hypoxic chamber for 24 h.
Fungal mats were flash frozen in liquid nitrogen and lyophilized
prior to total RNA extraction using TRIsure Reagent (Bioline)
according to the manufacturer’s instructions. RNA was further
purified using the RNeasy Mini Kit (Qiagen) and re-suspended in
DEPC-treated water. RNA integrity was confirmed with an
Agilent Technologies Bioanalyzer.
Microarray-based transcriptional profiling
Total RNA was reverse transcribed by priming with oligo dT
and utilizing aminoallyl-dUTP. The resultant cDNA was then
coupled to Cy3- and Cy5-labeled probes (GE Healthcare), and
hybridized to Aspergillus fumigatus version 3 microarrays from the
pathogen functional resources center (PFGRC) as described in the
TIGR standard operating procedures found at http://atarray.tigr.
org. Labeled cDNA from wild type grown in hypoxic conditions
was hybridized against cDNA from SDW1 grown in hypoxic
conditions. Data for each strain represents six independent
experiments and includes three dye swaps. Arrays were scanned
on an Axon 4000B scanner with GenePix software at the Montana
State University Functional Genomics Core facility (Axon
Instruments). Array signals were bulk-normalized and filtered for
flagged spots using MIDAS (available at http://www.tm4.org/
midas.html). Data were log-transformed (base 2) and filtered for
genes that contained data for at least three out of four arrays from
each strain, and missing values were calculated through K-nearest
neighbor algorithm using Significance Analysis of Microarrays
(SAM) software [73] prior to statistical analysis by SAM.
Statistically significant genes identified by SAM with 2-fold or
greater changes in expression are listed in Table 1. A Delta cutoff
in SAM that captured the maximum number of significant genes
with a false discovery rate of zero was utilized. Microarray data
has been deposited in the Gene Expression Omnibus (GEO) at the
National Center for Biotechnology Information (NCBI) series
accession number GSE12376.
Susceptibility testing
E-test strips (AB Biodisk, N.J.) plastic strips impregnated with a
gradient of Fluconazole, Voriconazole, Caspofungin, or Ampho-
tericin B were used per manufacturers’ instructions. Each strip was
placed onto a RPMI-1640 (Sigma Aldrich) agar plate containing a
lawn of conidia and growth inhibition was measured after 24 and
48 h by direct observation of the plates at 37uC. No difference in
results was observed between 24 and 48 h.
Sterol analyses
Sterols were extracted following published protocols [74]. Gas-
chromatography-Mass spectrometry analyses were performed with
a HP6890 GC coupled to a HP5973 mass selective detector.
Electron impact MS (70 eV, scanning from 50 to 550amu, at 2.94
intervals/sec) was performed using the following conditions: HP-5
column (30 m60.25 mm i.d., 0.25 mm film thickness), Helium as
carrier gas (1 ml/min), detector temperature 180uC, column
temperature 100uC to 300uC (100uC for 1 min, 7uC/min to
300uC then held for 15 min). All injections were run in splitless
mode.
Electron microscopy
Conidia and mycelia of wild type and SDW1 were examined by
transmission electron microscopy (TEM). Conidia released in
sterile water from 5-day-old GMM plates and mycelia grown in
liquid GMM for two days were collected by centrifugation at
50006g for 10 min. The conidial and mycelial pellets were coated
with 0.8% agarose and fixed in modified Karnovsky’s fixative
containing 2% paraformaldehyde and 2% (v/v) glutaraldehyde in
0.05 M sodium cacodylate buffer (pH 7.2) overnight at 4uC. After
washing three times with 0.05 M sodium cacodylate buffer
(pH 7.2) for 10 min each, samples were post-fixed with 1% (w/
v) osmium tetraoxide in the same buffer for 2 hours at 4uC. The
post-fixative was removed by washing briefly twice with distilled
water at room temperature and the samples were en bloc stained
with 0.5% uranyl acetate overnight at 4uC. The samples were then
dehydrated in a graded ethanol series, rinsed with propylene
oxide, and embedded in Eppon resin (Fluka AG, Zu ¨rich, CH).
Ultrathin sections cut from the Eppon-embedded material with
ultramicrotome (MT-X, RMC, USA) were collected on carbon-
coated grids, stained with 2% uranyl acetate for 3 min, and with
Reynold’s lead solution [75] for 3 min. Examination was
conducted with a JEM-1010 (JEOL, Tokyo, Japan) electron
microscope operating at 60 kV.
Conidia Germination assay
For the conidia germination assay, A. fumigatus strains were
grown in 25 ml GMM with 2% yeast extract. Cultures were
inoculated with approximately 10
6 conidia/ml. After 7 hours the
germination rate was determined by counting a total of 100 spores
and noting the number of germinated spores. Counting was
repeated three times for each strain and the mean and standard
deviation are reported.
Murine virulence assays
In this study two different mouse models were used to assess the
role of the transcription factor SrbA in fungal virulence. For the
persistently neutropenic mouse model we used outbred CD1
(Charles River Laboratory, Raleigh, NC) male mice (26 to 28 g in
size, 6–8 weeks old), which were housed six per cage and had
access to food and water ad libitum. Mice were immunosup-
pressed with intraperitoneal (i.p.) injections of cyclophosphamide
at 150 mg/kg 2 days prior to infection and with Kenalog injected
subcutaneously (s.c.) at 40 mg/kg 1 days prior to infection. On day
3 post-infection (p.i.), repeat injections were given with cyclophos-
phamide (150 mg/kg i.p.) and on day 6 p.i. with Kenalog (40 mg/
Characterization of a SREBP in A. fumigatus
PLoS Pathogens | www.plospathogens.org 15 November 2008 | Volume 4 | Issue 11 | e1000200kg s.c.). Twelve mice per A. fumigatus strain (CEA10, srbA-deficient
mutant SDW1, or the reconstituted strain SDW2) were infected
intranasally. For an alternative mouse model, we used breeder
mice with a null allele corresponding to the X-linked gp91
phox
component of NADPH oxidase (B6.129S6-Cyb
btm1Din). Breeding
pairs of these mice were obtained from the Jackson Laboratory
(Bar Harbor, Maine) and reared in the Animal Resource Center at
Montana State University. All animals were kept in specific-
pathogen-free housing, and all manipulations were approved by
the institutional internal review board (IACUC). To avoid
exposing gp91
phox2/2 mice to bacterial infections, they were
housed in microisolator cages in an environment of filtered air and
given autoclaved food ad libitum and prophylactic treatment with
sulfamethoxazole-trimethoprim in their sterile drinking water. The
animals were used at 8 to 13 weeks of age. The mice were
inoculated intratracheally following brief isoflurane inhalation,
returned to their cages, and monitored at least twice daily.
Infection inoculum was prepared by growing the A. fumigatus
isolates on GMM agar plates at 37uC for 3 days. Conidia were
harvested by washing the plate surface with sterile phosphate-
buffered saline-0.01% Tween 80. The resultant conidial suspen-
sion was adjusted to the desired concentration of 1610
6 conidia/
40 ml by hemacytometer count. Mice were observed for survival
for 14 days after A. fumigatus challenge. Any animals showing
distress were immediately sacrificed and recorded as deaths within
24 h. Mock mice were included in all experiments and inoculated
with sterile 0.01% Tween 80. Lungs from all mice sacrificed
during the experiment were removed for fungal burden assessment
and histopathology. Experiments were repeated in duplicates with
similar results. Survival was plotted on a Kaplan-Meier curve and
a log-rank test used to determine significance of pair-wise survival
(two-tailed P,0.01). No mock infected animals perished in either
murine model in all experiments.
Histopathology
For histopathology studies, additional gp91
phox2/2 mice were
infected as described above, and sacrificed at set time points of day
1 and day 4 after A. fumigatus challenge. When mice were
sacrificed, lungs were removed on that day. Lung tissue was fixed
in 10% phosphate-buffered formalin, embedded in paraffin,
sectioned at 5 mm, and stained with hematoxylin and eosin
(H&E) or Grocott methenamine silver (GMS) by using standard
histological techniques. Microscopic examinations were performed
on a Zeiss Axioscope 2-plus microscope and imaging system using
Zeiss Axiovision version 4.4 software. Semi-quantitative analysis of
inflammation and necrosis were scored on a scale of 1 to 5. The
scale consisted of: 1=0 to 24% lung involvement, 2=25–49%,
3=50–74%, 4=75–99% 5=100%. H&E stained whole lungs
from 4 mice infected with each respective strain were assessed to
determine the percentage involvement and scored accordingly on
days 1 and 4 of the infection in consultation with a pulmonary
immunologist.
Macrophage assays
Macrophage killing of conidia was measured by serial dilution
as previously described with slight modifications [76–78]. Briefly,
2.5610
5 RAW264.7 cells in a volume of 500 ml were inoculated
into 24 well tissue culture treated cell culture plates (Corning
Incorporated, Corning, NY) in DMEM complete media and
incubated overnight at 37uC, 5% CO2. A total of 1.25610
6 freshly
harvested A. fumigatus conidia of the respective strains in DMEM
complete media were inoculated into each well to give a
conidia:macrophage ratio of 5:1. Co-incubation was performed
at 37uC, 5% CO2 for 1 hour, after which media was removed and
cells were gently washed with 16phosphate buffered saline (PBS)
to remove non-phagocytosed conidia. At this time point, conidia
from each strain were harvested from macrophages in one well to
establish the baseline number of conidia engulfed. DMEM
complete media was added back to the non-harvested wells and
incubation proceeded for an additional 5 hours. Lysis of
macrophages was performed by treating the cells with 200 ml of
a 0.5% SDS solution for 10 minutes followed by addition of
200 ml of 16PBS. The percentage of colony forming units (CFU)
from conidia:macrophage co-incubations was determined relative
to control conidia harvested at the one hour time point. Controls
were performed by lysing macrophages as described above after
phagocytosis of conidia for 1 hour and CFU counts were set to
100%. Experiments were performed with triplicate wells and
repeated two times for each A. fumigatus strain.
Oxidative stress assay
For the oxidative stress assay, the A. fumigatus strains were grown
on GMM plates with and without H2O2. GMM plates with 1 and
2.5 mM H2O2 were prepared. Plates were inoculated with
approximately 100,000 spores in 5 ml and incubated at 37uC.
Sensitivity to oxidative stress was determined by comparing the
colony radius of 2-day-old cultures on plates with H2O2. The assay
was repeated three times for each concentration. Growth of each
strain on each plate was visually examined.
Statistical analysis
The software program Prism 5 (GraphPad, San Diego, Calif.)
was used for all statistical tests of significance (to P values of
#0.01). Normally, a two-sided t test was used to compare two
groups of data, with Welch’s correction being used if the groups
had unequal variances. In cases in which a deviation from a
normal distribution was suspected, a nonparametric test (Mann-
Whitney test) was also applied. In those cases, we found that both
the t test and Mann-Whitney test indicated the same results (i.e.,
both indicated significance or insignificance); however, typically
one test gave a more conservative (larger, but still ,0.01) P value.
The P values we report are always the conservative values. Log-
rank tests were utilized to determine significance of survival in
animal studies.
Supporting Information
Table S1 Primers Used in This Study
Found at: doi:10.1371/journal.ppat.1000200.s001 (0.03 MB
DOC)
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